Cargando…

T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils

BACKGROUND: α-Synuclein (α-syn) is the predominant protein in Lewy-body inclusions, which are pathological hallmarks of α-synucleinopathies, such as Parkinson’s disease (PD) and multiple system atrophy (MSA). Other hallmarks include activation of microglia, elevation of pro-inflammatory cytokines, a...

Descripción completa

Detalles Bibliográficos
Autores principales: George, Sonia, Tyson, Trevor, Rey, Nolwen L., Sheridan, Rachael, Peelaerts, Wouter, Becker, Katelyn, Schulz, Emily, Meyerdirk, Lindsay, Burmeister, Amanda R., von Linstow, Christian U., Steiner, Jennifer A., Galvis, Martha L. Escobar, Ma, Jiyan, Pospisilik, J. Andrew, Labrie, Viviane, Brundin, Lena, Brundin, Patrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150548/
https://www.ncbi.nlm.nih.gov/pubmed/33579871
http://dx.doi.org/10.3233/JPD-202351
_version_ 1783698177798438912
author George, Sonia
Tyson, Trevor
Rey, Nolwen L.
Sheridan, Rachael
Peelaerts, Wouter
Becker, Katelyn
Schulz, Emily
Meyerdirk, Lindsay
Burmeister, Amanda R.
von Linstow, Christian U.
Steiner, Jennifer A.
Galvis, Martha L. Escobar
Ma, Jiyan
Pospisilik, J. Andrew
Labrie, Viviane
Brundin, Lena
Brundin, Patrik
author_facet George, Sonia
Tyson, Trevor
Rey, Nolwen L.
Sheridan, Rachael
Peelaerts, Wouter
Becker, Katelyn
Schulz, Emily
Meyerdirk, Lindsay
Burmeister, Amanda R.
von Linstow, Christian U.
Steiner, Jennifer A.
Galvis, Martha L. Escobar
Ma, Jiyan
Pospisilik, J. Andrew
Labrie, Viviane
Brundin, Lena
Brundin, Patrik
author_sort George, Sonia
collection PubMed
description BACKGROUND: α-Synuclein (α-syn) is the predominant protein in Lewy-body inclusions, which are pathological hallmarks of α-synucleinopathies, such as Parkinson’s disease (PD) and multiple system atrophy (MSA). Other hallmarks include activation of microglia, elevation of pro-inflammatory cytokines, as well as the activation of T and B cells. These immune changes point towards a dysregulation of both the innate and the adaptive immune system. T cells have been shown to recognize epitopes derived from α-syn and altered populations of T cells have been found in PD and MSA patients, providing evidence that these cells can be key to the pathogenesis of the disease. OBJECTIVE: To study the role of the adaptive immune system with respect to α-syn pathology. METHODS: We injected human α-syn preformed fibrils (PFFs) into the striatum of immunocompromised mice (NSG) and assessed accumulation of phosphorylated α-syn pathology, proteinase K-resistant α-syn pathology and microgliosis in the striatum, substantia nigra and frontal cortex. We also assessed the impact of adoptive transfer of naïve T and B cells into PFF-injected immunocompromised mice. RESULTS: Compared to wildtype mice, NSG mice had an 8-fold increase in phosphorylated α-syn pathology in the substantia nigra. Reconstituting the T cell population decreased the accumulation of phosphorylated α-syn pathology and resulted in persistent microgliosis in the striatum when compared to non-transplanted mice. CONCLUSION: Our work provides evidence that T cells play a role in the pathogenesis of experimental α-synucleinopathy.
format Online
Article
Text
id pubmed-8150548
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-81505482021-05-26 T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils George, Sonia Tyson, Trevor Rey, Nolwen L. Sheridan, Rachael Peelaerts, Wouter Becker, Katelyn Schulz, Emily Meyerdirk, Lindsay Burmeister, Amanda R. von Linstow, Christian U. Steiner, Jennifer A. Galvis, Martha L. Escobar Ma, Jiyan Pospisilik, J. Andrew Labrie, Viviane Brundin, Lena Brundin, Patrik J Parkinsons Dis Research Report BACKGROUND: α-Synuclein (α-syn) is the predominant protein in Lewy-body inclusions, which are pathological hallmarks of α-synucleinopathies, such as Parkinson’s disease (PD) and multiple system atrophy (MSA). Other hallmarks include activation of microglia, elevation of pro-inflammatory cytokines, as well as the activation of T and B cells. These immune changes point towards a dysregulation of both the innate and the adaptive immune system. T cells have been shown to recognize epitopes derived from α-syn and altered populations of T cells have been found in PD and MSA patients, providing evidence that these cells can be key to the pathogenesis of the disease. OBJECTIVE: To study the role of the adaptive immune system with respect to α-syn pathology. METHODS: We injected human α-syn preformed fibrils (PFFs) into the striatum of immunocompromised mice (NSG) and assessed accumulation of phosphorylated α-syn pathology, proteinase K-resistant α-syn pathology and microgliosis in the striatum, substantia nigra and frontal cortex. We also assessed the impact of adoptive transfer of naïve T and B cells into PFF-injected immunocompromised mice. RESULTS: Compared to wildtype mice, NSG mice had an 8-fold increase in phosphorylated α-syn pathology in the substantia nigra. Reconstituting the T cell population decreased the accumulation of phosphorylated α-syn pathology and resulted in persistent microgliosis in the striatum when compared to non-transplanted mice. CONCLUSION: Our work provides evidence that T cells play a role in the pathogenesis of experimental α-synucleinopathy. IOS Press 2021-04-13 /pmc/articles/PMC8150548/ /pubmed/33579871 http://dx.doi.org/10.3233/JPD-202351 Text en © 2021 – The authors. Published by IOS Press https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Report
George, Sonia
Tyson, Trevor
Rey, Nolwen L.
Sheridan, Rachael
Peelaerts, Wouter
Becker, Katelyn
Schulz, Emily
Meyerdirk, Lindsay
Burmeister, Amanda R.
von Linstow, Christian U.
Steiner, Jennifer A.
Galvis, Martha L. Escobar
Ma, Jiyan
Pospisilik, J. Andrew
Labrie, Viviane
Brundin, Lena
Brundin, Patrik
T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils
title T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils
title_full T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils
title_fullStr T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils
title_full_unstemmed T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils
title_short T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils
title_sort t cells limit accumulation of aggregate pathology following intrastriatal injection of α-synuclein fibrils
topic Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150548/
https://www.ncbi.nlm.nih.gov/pubmed/33579871
http://dx.doi.org/10.3233/JPD-202351
work_keys_str_mv AT georgesonia tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils
AT tysontrevor tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils
AT reynolwenl tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils
AT sheridanrachael tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils
AT peelaertswouter tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils
AT beckerkatelyn tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils
AT schulzemily tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils
AT meyerdirklindsay tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils
AT burmeisteramandar tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils
AT vonlinstowchristianu tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils
AT steinerjennifera tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils
AT galvismarthalescobar tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils
AT majiyan tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils
AT pospisilikjandrew tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils
AT labrieviviane tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils
AT brundinlena tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils
AT brundinpatrik tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils